Skip to main content

People in the News: Apr 7, 2011


GenMark Diagnostics this week announced the appointment of Hany Massarany as president and CEO. Massarany will also join GenMark's board.

Massarany has served as president of Ventana Medical Systems and Head of Roche Tissue Diagnostics since 2009. Ventana was acquired by Roche in February 2008 for about $3.4 billion.

Prior to that, he held various positions with Ventana, including COO, executive vice president of worldwide operations, senior vice president of corporate strategy and development, and vice president of North American commercial operations.

Prior to Ventana, Massarany held executive management positions with Bayer Diagnostics and Chiron Diagnostics. He holds a BS in microbiology and immunology from Monash University and an MBA from Melbourne University.

Fluidigm said this week that Evan Jones has been appointed to the company's board of directors, and will join the board's compensation committee.

Jones is the managing member of jVen Capital, a life sciences investment firm. Prior to that, he was co-founder, chairman, and CEO of Digene. He is currently executive chairman of Opgen; and a board member of CAS Medical Systems and Veracyte.

The Scan

US Supports Patent Waivers

NPR reports that the Biden Administration has announced its support for waiving intellectual property protections for SARS-CoV-2 vaccines.

Vaccines Versus Variants

Two studies find the Pfizer-BioNTech SARS-CoV-2 vaccine to be effective against viral variants, and Moderna reports on booster shots to combat variants.

CRISPR for What Ails You

The Wall Street Journal writes that CRISPR-based therapies could someday be used to treat common conditions like heart attacks.

Nature Papers Review Integration of Single-Cell Assay Data, Present Approach to Detect Rare Variants

In Nature this week: review of ways to integrate data from single-cell assays, and more.